Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Messori

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Metal-Based Drugs|May 14, 2008
Binding of Antitumor Ruthenium(III) Complexes to Plasma ProteinsL Messori, F G Vilchez, R Vilaplana, et al.
Journal of Biomolecular Structure & Dynamics|December 1, 1991
1H-NMR investigation of the interaction of the amino terminal domain of the LexA repressor with a synthetic half-operatorG Ottleben, L Messori, H Rüterjans, et al.
Biochemistry|November 1, 1988
1H NMR spectroscopic characterization of binary and ternary complexes of cobalt(II) carboxypeptidase A with inhibitorsI Bertini, C Luchinat, L Messori, et al.
Journal of Inorganic Biochemistry|May 20, 2004
A comparative study of adduct formation between the anticancer ruthenium(III) compound HInd trans-[RuCl4(Ind)2] and serum proteinsF Piccioli, S Sabatini, L Messori, et al.
FEBS Letters|September 9, 1991
2D 1H NMR studies of oxidized 2(Fe4S4) ferredoxin from Clostridium pasteurianumI Bertini, F Briganti, C Luchinat, et al.
Journal of Inorganic Biochemistry|February 28, 2016
Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA=1,3,5-triaza-7-phosphaadamantane): Chemical and biological propertiesF Battistin, F Scaletti, G Balducci, et al.
European Journal of Biochemistry|March 1, 1992
1H-NMR studies on partially and fully reduced 2(4Fe-4S) ferredoxin from Clostridium pasteurianumI Bertini, F Briganti, C Luchinat, et al.
Chemico-Biological Interactions|March 21, 2000
Cytotoxicity and DNA binding properties of a chloro glycylhistidinate gold(III) complex (GHAu)S Carotti, G Marcon, M Marussich, et al.
Journal of Inorganic Biochemistry|May 1, 1997
Biological properties of two gold(III) complexes: AuCl3(Hpm) and AuCl2(pm)P Calamai, S Carotti, A Guerri, et al.
British Journal of Cancer|June 5, 2003
Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengersL Morbidelli, S Donnini, S Filippi, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Metal-Based Drugs|May 14, 2008
Binding of Antitumor Ruthenium(III) Complexes to Plasma ProteinsL Messori, F G Vilchez, R Vilaplana, et al.
Journal of Biomolecular Structure & Dynamics|December 1, 1991
1H-NMR investigation of the interaction of the amino terminal domain of the LexA repressor with a synthetic half-operatorG Ottleben, L Messori, H Rüterjans, et al.
Biochemistry|November 1, 1988
1H NMR spectroscopic characterization of binary and ternary complexes of cobalt(II) carboxypeptidase A with inhibitorsI Bertini, C Luchinat, L Messori, et al.
Journal of Inorganic Biochemistry|May 20, 2004
A comparative study of adduct formation between the anticancer ruthenium(III) compound HInd trans-[RuCl4(Ind)2] and serum proteinsF Piccioli, S Sabatini, L Messori, et al.
FEBS Letters|September 9, 1991
2D 1H NMR studies of oxidized 2(Fe4S4) ferredoxin from Clostridium pasteurianumI Bertini, F Briganti, C Luchinat, et al.
Journal of Inorganic Biochemistry|February 28, 2016
Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA=1,3,5-triaza-7-phosphaadamantane): Chemical and biological propertiesF Battistin, F Scaletti, G Balducci, et al.
European Journal of Biochemistry|March 1, 1992
1H-NMR studies on partially and fully reduced 2(4Fe-4S) ferredoxin from Clostridium pasteurianumI Bertini, F Briganti, C Luchinat, et al.
Chemico-Biological Interactions|March 21, 2000
Cytotoxicity and DNA binding properties of a chloro glycylhistidinate gold(III) complex (GHAu)S Carotti, G Marcon, M Marussich, et al.
Journal of Inorganic Biochemistry|May 1, 1997
Biological properties of two gold(III) complexes: AuCl3(Hpm) and AuCl2(pm)P Calamai, S Carotti, A Guerri, et al.
British Journal of Cancer|June 5, 2003
Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengersL Morbidelli, S Donnini, S Filippi, et al.
Pageof 6